Your session is about to expire
← Back to Search
Mindfulness-Based Interventions for Obsessive-Compulsive Disorder(MindOC Trial)
MindOC Trial Summary
This trial is testing whether mindfulness can be an effective treatment for OCD by reducing the suffering associated with the disorder.
MindOC Trial Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowMindOC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
MindOC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- People who are taking medications for OCD must be stabilized before starting this studyYou have a serious medical condition that may need immediate attention while receiving treatment.There is a possibility that you have a physical health problem.You have been diagnosed with a serious mental health condition, such as severe mood disorder, schizophrenia, or addiction.The person experiences symptoms that are clinically significant and meet the criteria for obsessive-compulsive disorder, as measured by the Yale-Brown Obsessive Compulsive Scale
- Group 1: Mindfulness-based Cognitive Therapy
- Group 2: Waitlist
- Group 3: Cognitive Behaviour Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I potentially qualify to participate in this experiment?
"Patients ages 18 to 65 with a current diagnosis of OCD can take part in this medical trial. Participation is contingent on the following conditions being met: participants must be taking an adequate daily dose (40mg/day) and duration (8 weeks minimum) of fluoxetine, as well as having a Yale-Brown Obsessive Compulsive Scale score exceeding 17."
Are there any open enrolment opportunities for this medical trial?
"As of the most recently updated information on clinicaltrials.gov, this medical trial has concluded its recruitment phase, which began in September 2021. Despite not looking for participants anymore, there are over 100 other studies that can be accessed at present."
Does this research protocol have a minimum age requirement?
"This particular medical trial is open to participants aged 18-65. There are 23 studies for minors and 67 trials available for those 65 years or older."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger